Calvarial Regeneration using Biomatrix-Encapsulated Skeletal Progenitors

使用生物基质封装的骨骼祖细胞进行颅骨再生

• 批准号: 7855466
• 负责人: Annelise Emily Barron
• 金额: $ 105.84万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-23 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7855466
• 关键词: 1 year old; Accidents; Address; Adipose tissue; Age-Years; Binding; Biomedical Engineering; Bone Cements; Bone Matrix; Bone Regeneration; Bone Transplantation; Calvaria; Cell Adhesion; Cell Survival; Cell Therapy; Cell Transplants; Cell surface; Cells; Cellularity; Cephalic; Chronic; Clinical; Complex; Congenital Abnormality; Congenital Disorders; Defect; Deformity; Development; Devices; Encapsulated; Face; Fibrous capsule of kidney; Fluorescence; Fluorescence-Activated Cell Sorting; Fluorescent in Situ Hybridization; Future; Gel; Genetic Transcription; Goals; Gold; Growth; Growth Factor; Head; Healed; Histology; Human; Hydrogels; Image; Immunodeficient Mouse; Implant; In Situ; Individual; Infant; Infection; Life; Liquid substance; Malignant Neoplasms; Membrane Proteins; Methods; Microcapsules drug delivery system; Microfluidic Microchips; Microfluidics; Modeling; Monitor; Morbidity - disease rate; Mus; Natural regeneration; Operative Surgical Procedures; Patients; Peptides; Population; Preclinical Testing; Process; Proteins; Protocols documentation; Public Health; Receptor Signaling; Risk; Role; Signal Pathway; Site; Skeleton; Speed; Staging; Stem cells; Structure; Surface; System; Techniques; Testing; Therapeutic; Time; Tissue Engineering; Tissues; Transfection; Translating; Translations; Transplantation; Trauma; Work; base; bone; bone morphogenetic protein 2; capsule; craniofacial; cranium; crosslink; detector; healing; improved; in vivo; innovation; interdisciplinary approach; interest; morphogens; novel; osteochondral tissue; osteogenic; point of care; progenitor; prospective; public health relevance; reconstruction; regenerative; research clinical testing; research study; response; scaffold; skeletal; skeletal regeneration; skeletal tissue; stem; stem cell biology; tissue regeneration; tomography; tool; two-photon

DESCRIPTION (provided by applicant): Debilitating craniofacial skeletal defects, which occur frequently as a result of congenital disorders, trauma, cancer, and surgical interventions, are some of the most challenging problems for reconstruction. While infants demonstrate the ability to heal large and complex calvarial defects, those older than one year of age have an insufficient healing response to even small skull defects. Although a plethora of strategies have been developed over the past century, the patchwork of methods currently available reflects the inadequacies of each therapeutic technique. In this regard, skeletal stem cell biology holds enormous untapped promise for future tissue engineering applications. The goal of this project is to make autogenous skeletal progenitor cell-based craniofacial skeletal regeneration a clinical reality. Using an interdisciplinary approach, we will bring together our expertise in stem cell biology, bioengineering, and craniofacial surgery to tackle the roadblocks to translation of cell-based skeletal tissue engineering. In Specific Aim 1, we will prospectively isolate pure populations of human skeletal progenitor cells from different tissues and identify key progenitor cell niche factors necessary for their expansion and differentiation. In Specific Aim 2, we will develop a novel high throughput, microfluidics-based FACS (MF-FACS) device for simultaneous isolation and encapsulation of individual skeletal progenitor cells in a hydrogel-based, microenvironment conductive to their regenerative capabilities. In Specific Aim 3, we will assess the regenerative potential of transplanted encapsulated skeletal progenitors in critical-sized calvarial defect models. The role of supplementary niche factors will be further assessed using a tunable macroscale hydrogel scaffolding material. We believe this highly innovative project will ultimately produce an effective cell-based craniofacial skeletal regeneration regiment suitable for clinical testing. PUBLIC HEALTH RELEVANCE: The current tools available to doctors to repair bone structures of the head and face damaged from accidents, birth defects or cancer are inadequate. Using cells that have been removed from the patient, this project seeks to identify, protect, and return only those cells capable of growing into new bone structures. We seek to improve public health by developing a point-of-care method for surgical reconstruction of living bone.

描述（由申请人提供）：由于先天性疾病、创伤、癌症和手术干预而经常发生的衰弱性颅面骨骼缺陷是重建的一些最具挑战性的问题。虽然婴儿表现出治愈大而复杂的颅骨缺损的能力，但一岁以上的婴儿即使对小的颅骨缺损也没有足够的愈合反应。尽管在过去的世纪中已经开发出了过多的策略，但目前可用的拼凑方法反映了每种治疗技术的不足。在这方面，骨骼干细胞生物学为未来的组织工程应用提供了巨大的未开发的前景。本课题的目标是使基于自体骨骼祖细胞的颅面骨骼再生成为临床现实。使用跨学科的方法，我们将汇集我们在干细胞生物学，生物工程和颅面外科的专业知识，以解决基于细胞的骨骼组织工程翻译的障碍。在具体目标1中，我们将前瞻性地分离来自不同组织的人骨骼祖细胞的纯群体，并确定其扩增和分化所需的关键祖细胞生态位因子。在具体目标2中，我们将开发一种新型的高通量，基于微流体的FACS（MF-FACS）设备，用于在基于水凝胶的微环境中同时分离和封装单个骨骼祖细胞，以促进其再生能力。在具体目标3中，我们将评估移植的封装骨骼祖细胞在临界大小的颅骨缺损模型中的再生潜力。补充生态位因素的作用将进一步评估使用可调宏观水凝胶支架材料。我们相信这个高度创新的项目将最终产生一个有效的基于细胞的颅面骨骼再生团适合临床测试。 公共卫生关系：目前，医生修复因事故、先天缺陷或癌症而受损的头部和面部骨骼结构的工具是不够的。利用从患者体内取出的细胞，该项目旨在识别、保护和恢复那些能够生长成新骨结构的细胞。我们寻求通过开发一种用于活骨手术重建的即时护理方法来改善公众健康。